Osteoporosis: A neuroskeletal disease?

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 3, 2009, Pages 455-459

  Takeda, Shu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Leptin; Neuromedin U; Osteoporosis; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEPTIN; NEUROMEDIN U; NEUROTRANSMITTER; PROPRANOLOL;

ADRENERGIC SYSTEM; BONE REMODELING; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; MOLECULAR CLOCK; MOLECULAR DYNAMICS; NERVE CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY;

ANIMALS; BONE REMODELING; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; HOMEOSTASIS; HUMANS; LEPTIN; NERVE REGENERATION; NEUROPEPTIDES; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 58149278861     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.08.002     Document Type: Short Survey

References (36)

1. Ahima R.S., and Flier J.S. Leptin. Annu Rev Physiol 62 (2000) 413-437
2. Arai M., Nagasawa T., Koshihara Y., Yamamoto S., and Togari A. Effects of [beta]-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta (BBA)-Mol Cell Res 1640 (2003) 137-142
3. Bonnet N., Laroche N., Vico L., Dolleans E., Benhamou C.L., and Courteix D. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 318 (2006) 1118-1127
4. Brighton P.J., Szekeres P.G., and Willars G.B. Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56 (2004) 231-248
5. Burguera B., Hofbauer L.C., Thomas T., Gori F., Evans G.L., Khosla S., et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142 (2001) 3546-3553
6. Cock T.A., Back J., Elefteriou F., Karsenty G., Kastner P., Chan S., et al. Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen. EMBO Rep 5 (2004) 1007-1012
7. Cooper C., and Melton L.J.I. Magnitude and impact of osteoporosis and fractures. In: Marcus R., Feldman D., and Kelsey J. (Eds). Osteoporosis (1996), Academic Press, San Diego 419-434
8. Cornish J., Callon K.E., Bava U., Lin C., Naot D., Hill B.L., et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175 (2002) 405-415
9. Dhillon H., Glatt V., Ferrari S.L., and Bouxsein M.L. β-Adrenergic receptor KO mice have increased bone mass and strength but are not protected from ovariectomy-induced bone loss. J Bone Miner Res 19 (2004) S32
10. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
11. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005) 514-520
12. Elefteriou F., Takeda S., Ebihara K., Magre J., Patano N., Kim C.A., et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101 (2004) 3258-3263
13. Fu L., Patel M.S., Bradley A., Wagner E.F., and Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 122 (2005) 803-815
14. Guidobono F., Pagani F., Sibilia V., Netti C., Lattuada N., Rapetti D., et al. Different skeletal regional response to continuous brain infusion of leptin in the rat. Peptides 27 (2006) 1426-1433
15. Hainerova I., Torekov S.S., Ek J., Finkova M., Borch-Johnsen K., Jorgensen T., et al. Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab 91 (2006) 5057-5063
16. Hamrick M.W., Della-Fera M.A., Choi Y.H., Pennington C., Hartzell D., and Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 20 (2005) 994-1001
17. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4 (2006) 341-348
18. Kondo H., Nifuji A., Takeda S., Ezura Y., Rittling S.R., Denhardt D.T., et al. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 280 (2005) 30192-30200
19. Marenzana M., De Souza R.L., and Chenu C. Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice. Bone 41 (2007) 206-215
20. Minkowitz B., Boskey A.L., Lane J.M., Pearlman H.S., and Vigorita V.J. Effects of propranolol on bone metabolism in the rat. J Orthop Res 9 (1991) 869-875
21. Moore R.E., Smith Ii C.K., Bailey C.S., Voelkel E.F., and Tashjian Jr. A.H. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 23 (1993) 301-315
22. Patel M.S., and Elefteriou F. The new field of neuroskeletal biology. Calcif Tissue Int 80 (2007) 337-347
23. Pierroz D.D., Bouxsein M.L., Rizzoli R., and Ferrari S.L. Combined treatment with a [beta]-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 39 (2006) 260-267
24. Pierroz D.D., Muzzin P., Glatt V., Bouxsein M.L., Rizzoli R., and Ferrari S.L. Bone loss following ovariectomy is maintained in absence of adrenergic receptor β1 and β2 signaling. J Bone Miner Res 20 (2004) S277
25. Pogoda P., Egermann M., Schnell J.C., Priemel M., Schilling A.F., Alini M., et al. Leptin inhibits bone formation not only in rodents, but also in sheep. J Bone Miner Res 21 (2006) 1591-1599
26. Reseland J.E., Syversen U., Bakke I., Qvigstad G., Eide L.G., Hjertner O., et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16 (2001) 1426-1433
27. Riggs B.L., and Melton III L.J. Involutional osteoporosis. N Engl J Med 314 (1986) 1676-1686
28. Sato S., Hanada R., Kimura A., Abe T., Matsumoto T., Iwasaki M., et al. Central control of bone remodeling by neuromedin U. Nat Med 13 (2007) 1234-1240
29. Steppan C., Crawford D., Chidsey-Frink K., Ke H., and Swick A. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Peptides 92 (2000) 73-78
30. Suzuki A., Palmer G., Bonjour J.P., and Caverzasio J. Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone 23 (1998) 197-203
31. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
32. Takeda S., and Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone 42 (2008) 837-840
33. Takeuchi T., Tsuboi T., Arai M., and Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61 (2001) 579-586
34. Tam J., Trembovler V., Di Marzo V., Petrosino S., Leo G., Alexandrovich A., et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signalling. FASEB J 22 (2008) 285-294
35. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., and Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140 (1999) 1630-1638
36. Wiens M., Etminan M., Gill S.S., and Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260 (2006) 350-362